Literature DB >> 18177473

Synpolydactyly: clinical and molecular advances.

S Malik1, K-H Grzeschik.   

Abstract

Synpolydactyly (SPD) is a rare limb deformity showing a distinctive combination of syndactyly and polydactyly. Of the nine non-syndromic syndactylies, it is clinically and genetically one of the most heterogeneous malformation. SPD families may show clinical features consistent with the Temtamy and McKusick criteria as well as additional phenotypic variants, which vary from case to case. In certain instances, these variants predominate in a given family, while the typical SPD features remain less explicit. We have reviewed all the clinical variants occurring in well-documented SPD families. We conclude that typical SPD features can be delineated from minor clinical variants. Then, we propose to lump all the phenotypic variants, manifesting themselves in SPD families into three categories: (i) typical SPD features, (ii) minor variants, and (iii) unusual phenotypes. Next, we discuss the likely reasons for the occurrence of minor variants and the obvious lack of penetrance in SPD families. Finally, we show that for the SPD phenotype associated with HOXD13 mutations, a straightforward genotype-phenotype correlation is weak. Our lumping and splitting scheme for SPD phenotypic variants could be useful for the understanding of this interesting malformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177473     DOI: 10.1111/j.1399-0004.2007.00935.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

1.  Occurrence of Synpolydactyly and Omphalocele in a Fetus with a HOXD13 Mutation.

Authors:  Periyasamy Radhakrishnan; Shalini S Nayak; Muralidhar V Pai; Anju Shukla; Katta M Girisha
Journal:  J Pediatr Genet       Date:  2017-04-10

Review 2.  Syndactyly: phenotypes, genetics and current classification.

Authors:  Sajid Malik
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

3.  Mutant Hoxd13 induces extra digits in a mouse model of synpolydactyly directly and by decreasing retinoic acid synthesis.

Authors:  Pia Kuss; Pablo Villavicencio-Lorini; Florian Witte; Joachim Klose; Andrea N Albrecht; Petra Seemann; Jochen Hecht; Stefan Mundlos
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

4.  The epidemiology, genetics and future management of syndactyly.

Authors:  D Jordan; S Hindocha; M Dhital; M Saleh; W Khan
Journal:  Open Orthop J       Date:  2012-03-23

5.  Advances in the Molecular Genetics of Non-syndromic Syndactyly.

Authors:  Hao Deng; Ting Tan
Journal:  Curr Genomics       Date:  2015-06       Impact factor: 2.236

6.  Mutations in the homeodomain of HOXD13 cause syndactyly type 1-c in two Chinese families.

Authors:  Limeng Dai; Dan Liu; Min Song; Xueqing Xu; Gang Xiong; Kang Yang; Kun Zhang; Hui Meng; Hong Guo; Yun Bai
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

7.  A nonsense mutation in the HOXD13 gene underlies synpolydactyly with incomplete penetrance.

Authors:  Mazen Kurban; Muhammad Wajid; Lynn Petukhova; Yutaka Shimomura; Angela M Christiano
Journal:  J Hum Genet       Date:  2011-08-04       Impact factor: 3.172

Review 8.  A Review of the Phenotype of Synpolydactyly Type 1 in Homozygous Patients: Defining the Relatively Long and Medially Deviated Big Toe with/without Cupping of the Forefoot as a Pathognomonic Feature in the Phenotype.

Authors:  Mohammad M Al-Qattan
Journal:  Biomed Res Int       Date:  2020-05-15       Impact factor: 3.411

9.  Genetic screening of 202 individuals with congenital limb malformations and requiring reconstructive surgery.

Authors:  D Furniss; S-H Kan; I B Taylor; D Johnson; P S Critchley; H P Giele; A O M Wilkie
Journal:  J Med Genet       Date:  2009-05-07       Impact factor: 6.318

10.  Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences.

Authors:  Sajid Malik; K M Girisha; Muhammad Wajid; Akhilesh K Roy; Shubha R Phadke; Sayedul Haque; Wasim Ahmad; Manuela C Koch; Karl-Heinz Grzeschik
Journal:  BMC Med Genet       Date:  2007-12-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.